Learn More About 2024 Bleeding Disorders Scholarships
The HANDI Resources Center Team is pleased to announce new 2024 scholarship opportunities available for the bleeding disorders community!
Government Relations Update - August & September 2023
Paving the Road Ahead
Get to Know the Nevada Chapter with Jacob Murdock
New MASAC Documents Approved on Physical Therapy, Gene Therapy Readiness, Vaccine Guidance, and Treatment
NHF Employee Highlight - Meet Nick Kallinicou!
Meet NHF's Chapter Development Specialist, Nick Kallinicou! Nick took his passion for meaningful and impactful work and joined NHF. He continues to be a vital part of the NHF community and assisting families and patients.
FDA Accepts Priority Review BLA for Hemophilia B Gene Therapy
The U.S. Food and Drug Administration (FDA) has accepted CSL Behring’s Biologics License Application (BLA) for priority review of etranacogene dezaparvovec, an investigational gene therapy for hemophilia B.
HANDI Team Reminder – Apply for 2022 Scholarships Now!
Public Health for Blood Disorders Series Now Available Online!
New Study Looks at Physical Activity Risk in Patients with Hemophilia A
uniQure and CSL Behring Announce Trial Updates for Hemophilia B Gene Therapy
Central Ohio Chapter Annual Dinner
Insights from African American communities with bleeding disorders
This session will present findings from a national needs assessment conducted by NBDF in partnership with the CDC about the experiences and needs of people with bleeding disorders within African American communities. The group will discuss implications for individuals, chapters, and partners to serve African American communities.